WhiteLab Genomics
YC W22Paris, FR · Founded 2019 · 40 employees · 1 known investors
WhiteLab Genomics uses AI and computational methods to analyze biological data and accelerate genomic drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to reduce timelines and de-risk the development of genomic medicines.
AI & Machine LearningBiotechDeep TechHealthtechArtificial IntelligenceGene TherapyCell TherapyGenomicsin /whitelabgenomics/@whitelabgycombinator.com ↗
Founders & leadership· Y Combinator alumni (W22)
DD
David Delbourgoin𝕏Founder
JC
Julien CottineauinFounder
Investors · 1
Competitors · 9
by search overlapCowles_Investments_StemCentrx4 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.
IDbyDNA4 shared keywords
Acquisition News Article3 shared keywords
Polaris Genomics3 shared keywordsPolaris Genomics develops the ADAPT Neuropsychiatric Biomarker Discovery Platform, combining a targeted neuropsychiatric gene panel, analytics engine, and machine learning to identify genomic biomarkers from liquid biopsy for mental health and brain conditions. It serves researchers and pharma, academic, clinical, CRO, and government partners developing biomarker-based diagnostics and therapeutics in neuropsychiatry.
Startupintros3 shared keywordsStartup Intros is a platform for early-stage founders that handles Delaware C-Corp incorporation (EIN, founder stock, 83(b) filing), cap-table management with 409A, and investor matching through a double opt-in system. It also provides fundraising tools such as a data room with audit logs and round-tracking, positioning itself as an operating system for founders raising a round.
Genomeweb3 shared keywordsGenomeWeb is a news and information publisher covering the molecular biology, genomics, and sequencing industry, reporting on business developments, research, and technology among life-science companies. Its content includes premium articles on commercial results, funding, and scientific developments for professionals in the genomics and diagnostics fields.
STAT Dx3 shared keywords
10x Genomics 1-color3 shared keywords
Diabetes Prevention Program3 shared keywords
Companies competing with WhiteLab Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
- Debiopharm Co-leads a Series A Round in Whitelab Genomics - Debiopharmdebiopharm.com · 2022
- WhiteLab Genomics raises $10M for AI-powered genomic therapies platformlabiotech.eu · 2022
- How WhiteLab Genomics is using AI to aid gene and cell therapy development • TechCrunchtechcrunch.com · 2022
- WhiteLab Genomics and the Accelerator for Technological Research in Genomic Therapies Announce Their Collaboration on Artificial Intelligence for the Bioproduction of Gene Therapiesbusinesswire.com · 2021
- WhiteLab Genomics raised $10 million Series A funding from Debiopharm Innovation Fund and Omnes Capital. | Nordic 9nordic9.com
